Mechanics Bank Trust Department Sells 600 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Mechanics Bank Trust Department trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 20.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,400 shares of the financial services provider’s stock after selling 600 shares during the quarter. Mechanics Bank Trust Department’s holdings in iShares Biotechnology ETF were worth $317,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of IBB. BNP Paribas Financial Markets raised its stake in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares in the last quarter. Commerce Bank increased its holdings in shares of iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock worth $108,234,000 after purchasing an additional 12,921 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares in the last quarter. Main Management ETF Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 2.5% in the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after buying an additional 14,535 shares during the period. Finally, Aprio Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $18,476,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.2 %

Shares of NASDAQ IBB opened at $132.65 on Tuesday. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The business has a fifty day moving average price of $136.32 and a two-hundred day moving average price of $141.84.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.